Medicinal Products

Budelin Novolizer 200 mikrograma/dozi prašak inhalata

Name Budelin Novolizer 200 mikrograma/dozi prašak inhalata
Former Name Tafen Novolizer 200 µg prašak za inhaliranje
Marketing Authorisation Number HR-H-730386222
Active Substance budezonid
Composition jedna inhalacijska doza sadržava 200 mikrograma budezonida
Pharmaceutical Form prašak inhalata
Packaging [MA Number for Packaging] 1 uložak i 1 inhalator (200 doza), u kutiji  [HR-H-730386222-01]
1 uložak (200 doza), u kutiji  [HR-H-730386222-02]
Manufacturer McDermott Laboratories Limited, t/a Mylan Dublin Respiratory, Dublin 13, Irska
A&M Stabtest GmbH, Mainz, Njemačka
Marketing Authorisation Holder Viatris Hrvatska d.o.o., Koranska 2, Zagreb, Hrvatska
Marketing Authorisation Date 31.01.2018
MA Period of Validity unlimited
Classification Number UP/I-530-09/13-02/471
Registration Number 381-12-01/30-18-27
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code R03BA02
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Back